Topoisomerase 3b is dispensable for replication of a positive-sense RNA virus--murine coronavirus

Antiviral Res. 2022 Dec:208:105451. doi: 10.1016/j.antiviral.2022.105451. Epub 2022 Oct 31.

Abstract

A recent study demonstrated that a DNA-RNA dual-activity topoisomerase complex, TOP3B-TDRD3, is required for normal replication of positive-sense RNA viruses, including several human flaviviruses and coronaviruses; and the authors proposed that TOP3B is a target of antiviral drugs. Here we examined this hypothesis by investigating whether inactivation of Top3b can inhibit the replication of a mouse coronavirus, MHV, using cell lines and mice that are inactivated of Top3b or Tdrd3. We found that Top3b-KO or Tdrd3-KO cell lines generated by different CRISPR-CAS9 guide RNAs have variable effects on MHV replication. In addition, we did not find significant changes of MHV replication in brains or lungs in Top3B-KO mice. Moreover, immunostaining showed that Top3b proteins are not co-localized with MHV replication complexes but rather, localized in stress granules in the MHV-infected cells. Our results suggest that Top3b does not have a universal role in promoting replication of positive-sense RNA virus, and cautions should be taken when targeting it to develop anti-viral drugs.

Keywords: Coronavirus; MHV; SARS; TDRD3; TOP3B; Topoisomerase.

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology
  • Cell Line
  • Coronavirus Infections* / drug therapy
  • Coronavirus* / genetics
  • Mice
  • Murine hepatitis virus* / genetics
  • Murine hepatitis virus* / metabolism
  • Proteins
  • RNA Viruses*
  • RNA, Viral / genetics
  • RNA, Viral / metabolism
  • Virus Replication

Substances

  • Antiviral Agents
  • Proteins
  • RNA, Viral
  • Tdrd3 protein, human